Display options
Share it on

Psychiatry Investig. 2011 Sep;8(3):207-13. doi: 10.4306/pi.2011.8.3.207. Epub 2011 Aug 02.

Effect of initial ziprasidone dose on treatment outcome of korean patients with acute manic or mixed episodes.

Psychiatry investigation

Young Sup Woo, Won-Myong Bahk, Soo Hyun Jo, Bo-Hyun Yoon, Jung Goo Lee, Won Kim, Jong-Hyun Jeong, Jeong Seok Seo, Kyung Joon Min, Duk-In Jon

Affiliations

  1. Department of Psychiatry, Yeouido St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

PMID: 21994507 PMCID: PMC3182385 DOI: 10.4306/pi.2011.8.3.207

Abstract

OBJECTIVE: We investigated the efficacy and tolerability of ziprasidone combined with divalproex to determine the relationship between the initial dose of ziprasidone and the treatment effect among Korean patients with acute bipolar manic or mixed disorders.

METHODS: This study was a 6-week, open-label, prospective investigation of Korean patients with an acute manic or mixed episode of bipolar disorder. Sixty-five patients were recruited. The patients were categorized based on the initial dose of ziprasidone as follows: low (20-79 mg/day) and standard (80 mg/day). Ziprasidone was given in combination with divalproex in flexible doses, according to the clinical response and tolerability.

RESULTS: The response and remission rates were significantly higher in the standard-dose group than the low-dose group. The combination of ziprasidone and divalproex was well-tolerated and adverse events were mostly mild with no statistically significant increase in body weight.

CONCLUSION: The results of this study showed that a standard starting dose of ziprasidone in combination with divalproex for bipolar disorder is more effective than a low starting dose.

Keywords: Bipolar disorder; Divalproex; Initial dose; Manic episode; Ziprasidone

References

  1. J Clin Psychopharmacol. 2005 Aug;25(4):301-10 - PubMed
  2. J Affect Disord. 2008 Jan;105(1-3):45-52 - PubMed
  3. Am J Psychiatry. 1983 Apr;140(4):490-1 - PubMed
  4. Am J Psychiatry. 2003 Apr;160(4):741-8 - PubMed
  5. Schizophr Res. 2006 Apr;83(2-3):285-92 - PubMed
  6. Am J Med. 2005 Apr;118 Suppl 2:15S-22S - PubMed
  7. Am J Psychiatry. 2002 Jul;159(7):1146-54 - PubMed
  8. Br J Soc Clin Psychol. 1967 Dec;6(4):278-96 - PubMed
  9. J Clin Psychiatry. 2004;65 Suppl 7:4-18; quiz 19-20 - PubMed
  10. CNS Spectr. 2005 Nov;10(11 Suppl 17):1-20 - PubMed
  11. Br J Psychiatry. 2004 Apr;184:337-45 - PubMed
  12. J Clin Psychiatry. 2004 Dec;65(12):1679-87 - PubMed
  13. J Clin Psychiatry. 2004 Dec;65(12):1624-33 - PubMed
  14. J Clin Psychopharmacol. 2005 Aug;25(4):388-91 - PubMed
  15. Acta Psychiatr Scand. 2007 Jan;115(1):12-20 - PubMed
  16. Bipolar Disord. 2009 Aug;11(5):453-73 - PubMed
  17. Br J Psychiatry. 1978 Nov;133:429-35 - PubMed
  18. J Pharmacol Exp Ther. 1995 Oct;275(1):101-13 - PubMed
  19. Acta Psychiatr Scand Suppl. 1970;212:11-9 - PubMed
  20. Schizophr Res. 2009 Mar;108(1-3):238-44 - PubMed
  21. Am J Psychiatry. 1999 Nov;156(11):1686-96 - PubMed
  22. Psychiatry Clin Neurosci. 2004 Feb;58(1):61-7 - PubMed
  23. J Clin Psychopharmacol. 2004 Dec;24(6):599-606 - PubMed
  24. Ann Pharmacother. 1997 Nov;31(11):1360-9 - PubMed
  25. J Clin Psychopharmacol. 2001 Feb;21(1):27-35 - PubMed
  26. Arch Gen Psychiatry. 2002 Jan;59(1):62-9 - PubMed
  27. Aust N Z J Psychiatry. 1992 Jun;26(2):262-4 - PubMed
  28. Am J Psychiatry. 2003 Jan;160(1):112-7 - PubMed

Publication Types